Abstract
Warfarin, a vitamin K antagonist, is widely used for the prophylaxis and treatment of thromboembolic disease. While guidelines exist for management of a supratherapeutic international normalized ratio following therapeutic warfarin use, these guidelines are not designed for management of the acute warfarin overdose. There is a paucity of literature describing the latter. The primary objective of this manuscript is to characterize the coagulopathy and describe the bleeding events that occur after a warfarin overdose. A secondary goal is to describe the amount of vitamin K administered to patients presenting with warfarin overdoses. A retrospective chart review of patients admitted with an acute warfarin overdose at two tertiary care medical centers in the USA was conducted. Clinical characteristics were abstracted, and bleeding categories (major, minor, trivial) were defined a priori. Twenty-three patients were admitted during the time period; males accounted for 15/23 (62.5 %) subjects. The median (interquartile range (IQR)) age was 43 (32–48.5) years. Seventeen subjects received vitamin K, with a median (IQR) dose of 15 (10–50) mg. The maximal total amount of vitamin K administered to a single patient during the index hospitalization was 110 mg. Three bleeding events occurred; one classified as major, and two as minor. All patients made a full recovery. In this case series of acute warfarin overdose, nearly all patients developed a coagulopathy, and nearly three-quarters of patients received vitamin K. Bleeding events occurred in a minority of patients.
Similar content being viewed by others
References
Limdi NA, Veenstra DL (2008) Warfarin pharmacogenetics. Pharmacotherapy 28:1084–1097
Kimmel SE (2008) Warfarin therapy: in need of improvement after all these years. Expert Opin Pharmacother 9:677–686
Li T, Chang CY, Jin DY et al (2004) Identification of the gene for vitamin K epoxide reductase. Nature 247:541–544
Hirsh J, Dalen JE, Anderson DR et al (2001) Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 119(1Suppl):8S–21S
Levine M, Ruha AM, Goldstein JN (2012) Can asymptomatic patients with a supratherapeutic INR be safely treated as outpatients? Ann Emerg Med 59:318–320
Guyatt GH, Akl EA, Crowther M et al (2012) Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141:7S–47S
Baker RL, Coughlin PB, Gallus AS et al (2004) Warfarin-reversal: consensus guidelines, on behalf of the Australasian Society of Thrombosis and Haemostasis. Med J Aust 181:492–497
Isbister GK, Hackett LP, Whyte IM (2003) Intentional warfarin overdose. Ther Drug Monit 25:715–722
Hackett LP, Ilett KF, Chester A (1985) Plasma warfarin concentrations after a massive overdose. Med J Aust 142:642–643
Bjornsson TD, Blaschke TF (1978) Vitamin K disposition and therapy of warfarin overdose. Lancet 14:846–847
Renowden S, Westmoreland D, White JP et al (1985) Oral cholestyramine increases elimination of warfarin after overdose. Br Med J 291:513–514
Toolis F, Robson RH, Critchley JA (1981) Warfarin poisoning in patients with prosthetic heart valves. Br Med J (Clin Res Ed) 283:581–582
Bronstein AC, Spyker DA, Cantilena LR (2012) 2011 Annual report of the American Association of Poison Control Centers' National Poison Data System: 29th Annual report. Clin Toxicol 50:911–1164
Jaffer A, Bragg L (2003) Practical tips for warfarin dosing and monitoring. Cleve Clin J Med 70:361–371
D'Angelo A, Della Valle P, Crippa L et al (2002) Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels, and in vivo prothrombin activation during the early and steady phases of oral anticoagulant therapy. Haematologica 87:1074–1080
Crowther MA, Ageno W, Garcia D et al (2009) Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial. Ann Intern Med 150:293–300
Denas G, Marzot F, Offelli P et al (2009) Effectiveness and safety of a management protocol to correct over-anticoagulation with oral vitamin K: a retrospective study of 1,043 cases. J Thromb Thrombolysis 27:340–347
Hylek EM, Chang YC, Skates SJ et al (2000) Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation. Arch Intern Med 160:1612–1617
Gilbert EH, Lowenstein SR, Koziol-McLain J et al (1996) Chart reviews in emergency medicine research: what are the methods? Ann Emerg Med 27:305–308
Conflict of Interest
There are no financial, litigational, or other conflicts of interest to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Levine, M., Pizon, A.F., Padilla-Jones, A. et al. Warfarin Overdose: A 25-Year Experience. J. Med. Toxicol. 10, 156–164 (2014). https://doi.org/10.1007/s13181-013-0378-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13181-013-0378-8